Advancing the Future of Health and Life Sciences

Scientific discovery and technological innovation are transforming how we understand, prevent and treat disease.

Harvor Capital seeks opportunities across biotech and life sciences where advances in science, data and technology can translate into meaningful improvements in healthcare and create enduring value.

We invest selectively in businesses with differentiated technologies, strong scientific foundations and the potential to address significant unmet needs.

Our approach spans emerging platforms as well as established technologies that can benefit from continued innovation and broader adoption.

Areas of Interest

• Biotechnology & Therapeutics — Novel approaches to the development and delivery of therapies.

  
  

• Diagnostics — Technologies enabling earlier, more accurate and efficient detection of disease.
  
  

• Digital Health — Technology-enabled solutions improving healthcare delivery, access and patient outcomes.
  
  

• Medical Technologies — Innovative devices, tools and technologies supporting modern healthcare.
  
  

• Computational Biology — The application of data, computing and AI to biological research and discovery.
  
  

• Life Sciences Platforms — Infrastructure, tools and services supporting research, development and healthcare innovation.

We look beyond individual technologies to understand the underlying science, market opportunity, regulatory environment and ability of a business to scale.

Our objective is to partner with teams positioned to translate scientific progress into sustainable, commercially viable solutions.

Investing where science, technology and human health converge.